生物
2型糖尿病
病理生理学
糖尿病
肠道菌群
生物信息学
计算生物学
免疫学
内分泌学
作者
Daniel P Baars,Marcos F. Fondevila,Abraham S. Meijnikman,Max Nieuwdorp
标识
DOI:10.1016/j.chom.2024.07.017
摘要
The inhabitants of our intestines, collectively called the gut microbiome, comprise fungi, viruses, and bacterial strains. These microorganisms are involved in the fermentation of dietary compounds and the regulation of our adaptive and innate immune systems. Less known is the reciprocal interaction between the gut microbiota and type 2 diabetes mellitus (T2DM), as well as their role in modifying therapies to reduce associated morbidity and mortality. In this review, we aim to discuss the existing literature on gut microbial strains and their diet-derived metabolites involved in T2DM. We also explore the potential diagnostics and therapeutic avenues the gut microbiota presents for targeted T2DM management. Personalized treatment plans, driven by diet and medication based on the patient's microbiome and clinical markers, could optimize therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI